LFWD vs. MLSS, RBOT, NTRB, CLGN, COCH, INGN, CLNN, OKYO, RFL, and XAIR
Should you be buying ReWalk Robotics stock or one of its competitors? The main competitors of ReWalk Robotics include Milestone Scientific (MLSS), Vicarious Surgical (RBOT), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Inogen (INGN), Clene (CLNN), OKYO Pharma (OKYO), Rafael (RFL), and Beyond Air (XAIR). These companies are all part of the "medical" sector.
ReWalk Robotics (NASDAQ:LFWD) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, community ranking, profitability, valuation and analyst recommendations.
ReWalk Robotics presently has a consensus price target of $9.00, indicating a potential upside of 89.47%. Given ReWalk Robotics' higher possible upside, research analysts clearly believe ReWalk Robotics is more favorable than Milestone Scientific.
Milestone Scientific has a net margin of -70.50% compared to ReWalk Robotics' net margin of -159.76%. ReWalk Robotics' return on equity of -28.19% beat Milestone Scientific's return on equity.
ReWalk Robotics received 2 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 100.00% of users gave ReWalk Robotics an outperform vote while only 0.00% of users gave Milestone Scientific an outperform vote.
26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by company insiders. Comparatively, 25.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
ReWalk Robotics has a beta of 1.99, meaning that its stock price is 99% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.
Milestone Scientific has lower revenue, but higher earnings than ReWalk Robotics. Milestone Scientific is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Milestone Scientific had 1 more articles in the media than ReWalk Robotics. MarketBeat recorded 1 mentions for Milestone Scientific and 0 mentions for ReWalk Robotics. ReWalk Robotics' average media sentiment score of 0.67 beat Milestone Scientific's score of 0.00 indicating that ReWalk Robotics is being referred to more favorably in the media.
Summary
ReWalk Robotics beats Milestone Scientific on 11 of the 17 factors compared between the two stocks.
Get ReWalk Robotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ReWalk Robotics Competitors List
Related Companies and Tools
